Establishment of an In vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Chattopadhyay, Rana ^a   Velmurugan, Soundarapandian ^a   Chakiath, Chinnamma ^a   Donkor, Lucy Andrews ^a   Milhous, Wilbur ^b,d   Barnwell, John W ^c   Collins, William E ^c   Hoffman, Stephen L ^a  

^a SANARIA INC   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMAQUINE; ANTIMALARIAL AGENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOSE RESPONSE; DRUG SCREENING; HEPATITIS; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; NONHUMAN; PARASITE DEVELOPMENT; PARASITE IDENTIFICATION; PILOT STUDY; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; SPOROZOITE; ANIMAL; ANOPHELES; CHEMISTRY; CRYOPRESERVATION; DISEASE MODEL; DRUG EFFECT; FLUORESCENCE MICROSCOPY; LIVER; LIVER CELL CARCINOMA; METABOLISM; METHODOLOGY; PAN TROGLODYTES; PARASITOLOGY; SALIVARY GLAND;

PLASMODIUM VIVAX;

ANIMALS; ANOPHELES; ANTIMALARIALS; CARCINOMA, HEPATOCELLULAR; CRYOPRESERVATION; DISEASE MODELS, ANIMAL; HEPATOCYTES; HUMANS; LIVER; MALARIA, VIVAX; MICROSCOPY, FLUORESCENCE; PAN TROGLODYTES; PLASMODIUM VIVAX; PRIMAQUINE; SALIVARY GLANDS; SPOROZOITES;

EID: 78650164971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014275     Document Type: Article

References (28)

1. Mendis K, Sina BJ, Marchesini P, Carter R (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64(Suppl 1-2): 97-106.
2. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, et al. (2007) Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 79-87.
3. Sina B (2002) Focus on Plasmodium vivax. Trends Parasitol 18: 287-289.
4. WHO (2008) World Malaria Report.
5. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, et al. (2009) Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 80: 194-198.
6. Sharma A, Khanduri U (2009) How benign is benign tertian malaria? J Vector Borne Dis 46: 141-144.
7. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, et al. (2008) Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia PLoS Medicine. 5: 1-10.
8. Fernandez-Becerra C, Pinazo MJ, Gonzalez A, Alonso PL, del Portillo HA, et al. (2009) Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria. Malar J 8: 55.
9. Krotoski WA, Collins WE, Bray RS, Garnham PC, Cogswell FB, et al. (1982) Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection Am J Trop Med Hyg 31: 1291-1293.
10. Krotoski WA (1985) Discovery of the hypnozoite and a new theory of malarial relapse. Trans R Soc Trop Med Hyg 79: 1-11.
11. Craig AA, Kain KC (1996) Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. J Infect Dis 174: 373-379.
12. Kirchgatter K, del Portillo HA (1998) Molecular analysis of Plasmodium vivax relapses using the MSP1 molecule as a genetic marker. J Infect Dis 177: 511-515.
13. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, et al. (2007) Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis 195: 927-933.
14. Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q (2007) Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis 195: 934-941.
15. Baird JK, Hoffman SL (2004) Primaquine therapy for malaria. Clin Infect Dis 39: 1336-1345.
16. Kitchener S, Nasveld P, Edstein MD (2007) Tafenoquine for the treatment of recurrent Plasmodium vivax malaria. Am J Trop Med Hyg 76: 494-496.
17. Mazier D, Landau I, Druilhe P, Miltgen F, Guguen-Guillouzo C, et al. (1984) Cultivation of the liver forms of Plasmodium vivax in human hepatocytes. Nature 307: 367-369.
18. Hollingdale MR, Collins WE, Campbell CC, Schwartz AL (1985) In Vitro Culture of Two Populations (Dividing and Nondividing) of Exoerythrocytic Parasites of Plasmodium vivax. Am J Trop Med Hyg 34: 216-222.
19. Sattabongkot J, Yimamnuaychoke N, Leelaudomlipi S, Rasameesoraj M, Jenwithisuk R, et al. (2006) Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg 74: 708-715.
20. Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, et al. (2010) Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 6: 97-106.
21. Bates MD, Meshnick SR, Sigler CI, Leland P, Hollingdale MR (1990) In vitro effects of primaquine and primaquine metabolites on exoerythrocytic stages of Plasmodium berghei. Am J Trop Med Hyg 42: 532-537.
22. Fisk TL, Millet P, Collins WE, Nguyen-Dinh P (1989) In vitro activity of antimalarial compounds on the exoerythrocytic stages of Plasmodium cynomolgi and P. knowlesi. Am J Trop Med Hyg 40: 235-239.
23. Sullivan JS, Strobert E, Yang C, Morris CL, Galland GG, et al. (2001) Adaptation of a strain of Plasmodium vivax from India to New World monkeys, chimpanzees, and anopheline mosquitoes. J Parasitol 87: 1398-1403.
24. Charoenvit Y, Collins WE, Jones TR, Millet P, Yuan L, et al. (1991) Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science 251: 668-671.
25. Aley SB, Barnwell JW, Bates MD, Collins WE, Hollingdale MR (1987) Plasmodium vivax: exoerythrocytic schizonts recognized by monoclonal antibodies against blood-stage schizonts. Exp Parasitol 64: 188-194.
26. Roberts L (2008) Infectious disease. New malaria plan called ambitious by some, unrealistic by others. Science 322: 26-27.
27. Smoak BL, DeFraites RF, Magill AJ, Kain KC, Wellde BT (1997) Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia. Am J Trop Med Hyg 56: 231-234.
28. Hollingdale MR, Collins WE, Campbell CC (1986) In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells. Am J Trop Med Hyg 35: 275-276.